Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 34.60% | 55.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 40.04% | 56.03% | |||
| Operating Income | -40.04% | -56.03% | |||
| Income Before Tax | -53.51% | -58.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -53.51% | -58.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.51% | -58.11% | |||
| EBIT | -40.04% | -56.03% | |||
| EBITDA | -40.31% | -56.85% | |||
| EPS Basic | -51.00% | -56.60% | |||
| Normalized Basic EPS | -50.71% | -56.67% | |||
| EPS Diluted | -51.00% | -56.60% | |||
| Normalized Diluted EPS | -50.71% | -56.67% | |||
| Average Basic Shares Outstanding | 1.77% | 1.04% | |||
| Average Diluted Shares Outstanding | 1.77% | 1.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||